Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment . Braz. J. Pharm. Sci. [Internet]. 2014 Apr. 1 [cited 2024 May 16];50(2):345-52. Available from: https://revistas.usp.br/bjps/article/view/86942